Intended for healthcare professionals

Rapid response to:


Drug companies are fined more than £260m for overcharging NHS for hydrocortisone pills

BMJ 2021; 374 doi: (Published 15 July 2021) Cite this as: BMJ 2021;374:n1809

Rapid Response:

Name and Shame

Dear Editor

"The impact on the NHS – and ultimately the UK taxpayer – was significant. Before April 2008, the NHS was spending approximately £500,000 a year on hydrocortisone tablets. This had risen to over £80 million by 2016." (1)

I think it would be appropriate if prison sentences follow.


Competing interests: No competing interests

17 July 2021
Peter Selley
Retired GP
Crediton, Devon